Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Authors
Keywords
Docetaxel, Bone Metastasis, Enzalutamide, Cabazitaxel, Abiraterone Acetate
Journal
DRUGS
Volume 74, Issue 5, Pages 579-586
Publisher
Springer Nature
Online
2014-03-07
DOI
10.1007/s40265-014-0198-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Changing Natural History of Metastatic Prostate Cancer
- (2013) Ajjai Alva et al. CANCER JOURNAL
- Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
- (2013) Jorge A. Carrasquillo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms
- (2013) Aurelius Omlin et al. EUROPEAN UROLOGY
- 714 PAIN AND QUALITY OF LIFE (QOL) ANALYSES FROM THE PHASE 3 RANDOMIZED ALSYMPCA STUDY WITH RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS WITH BONE METASTASES
- (2013) Michael Tomblyn et al. JOURNAL OF UROLOGY
- Castration-Resistant Prostate Cancer: AUA Guideline
- (2013) Michael S. Cookson et al. JOURNAL OF UROLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
- (2013) Harrison et al. Cancer Management and Research
- Castration-resistant metastatic prostate cancer: current status and treatment possibilities
- (2012) Joan Carles et al. Clinical & Translational Oncology
- Molecular Pathways: Targeted -Particle Radiation Therapy
- (2012) K. E. Baidoo et al. CLINICAL CANCER RESEARCH
- Guidelines for the management of castrate-resistant prostate cancer
- (2012) Fred Saad et al. CUAJ-Canadian Urological Association Journal
- Radiation-based approaches for therapy and palliation of advanced prostate cancer
- (2012) Brian Lewis et al. CURRENT OPINION IN UROLOGY
- Management of Metastatic Castration-Resistant Prostate Cancer
- (2012) Deborah Mukherji et al. DRUGS
- Dosimetry of 223Ra-chloride: dose to normal organs and tissues
- (2012) Michael Lassmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer
- (2012) Christopher C. Parker et al. EUROPEAN UROLOGY
- The changing landscape in the treatment of metastatic castration-resistant prostate cancer
- (2012) Joelle El-Amm et al. Therapeutic Advances in Medical Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)
- (2011) C. Parker et al. EUROPEAN JOURNAL OF CANCER
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF CLINICAL ONCOLOGY
- 855 Lack of protective effect by hypoxia on alpha particle radiation from radium-223
- (2010) H. Heier-Baardson et al. EJC SUPPLEMENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started